besremi
(ropeginterferon alfa-2b)Pharmaessentia Usa Corporation
Usage: BESREMi is indicated for the treatment of adults with polycythemia vera.
Medications for Polycythemia Vera
3 results
jakafi
(ruxolitinib)Incyte CorporationUsage: Jakafi is indicated for treating intermediate or high-risk myelofibrosis, polycythemia vera in adults intolerant to hydroxyurea, and steroid-refractory acute and chronic graft-versus-host disease in patients aged 12 and older who have not responded to prior systemic therapies.p32 sodium phosphate
(P32 Sodium Phosphate)AnazaoHealth CorporationUsage: P32 sodium phosphate is indicated for treating polycythemia vera and is effective in chronic myelocytic and chronic lymphocytic leukemia. It may also be used palliatively in selected patients with multiple skeletal metastases.